创远信科（上海）技术股份有限公司 证券代码：831961 证券简称：创远信科 公告编号：2025-035 关于参加 2025 年上海辖区 上市公司年报集体业绩说明会的预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 说明会类型 创远信科（上海）技术股份有限公司（以下简称"公司"）已 于 2025 年 4 月 25 日在北京证券交易所指定披露平台（www.bse.cn） 发布了公司《2024 年年度报告》（公告编号：2025-012），为方便广 大投资者更全面深入地了解公司 2024 年年度经营成果、财务状况， 公司计划于 2025 年 5 月 15 日（星期四）15:00-16:30 参加 2025 年 上海辖区上市公司年报集体业绩说明会，就投资者关心的问题进行 交流。 本次投资者说明会以网络互动形式召开，公司将针对 2024 年 度的经营成果及财务指标的具体情况与投资者进行互动交流和沟 通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一）会议召 ...

Group 1: Financial Performance - In Q1 2025, the company achieved a revenue of 60.91 million yuan, representing a year-on-year growth of 27.47% [4] - The net profit attributable to shareholders and net cash flow from operating activities also showed significant growth compared to the same period last year [4] Group 2: Strategic Development - The company is focusing on communication testing services in the low-altitude economy and satellite internet sectors as part of its "1+3" development strategy [5] - New products include the mmWave 5G integrated testing system and the Rainbow series for low-altitude signal monitoring, aimed at supporting the commercial development of the low-altitude economy [5] Group 3: R&D and Technological Advancements - The company is actively involved in 5G/6G and millimeter-wave communication testing technology research, with several national-level projects underway [6] - It has successfully applied for 13 major national projects in 2024, leading to breakthroughs in key technologies such as ultra-high-speed baseband signal processing [8] Group 4: Market Value Management - The company emphasizes the importance of market value management, with a dedicated office to oversee this function [9] - It aims to enhance governance, operational efficiency, and profitability while ensuring transparent communication with investors [10]

A股6G概念股拉升，创远信科、硕贝德涨超10%，陕西华达涨超8%，广哈通信、通宇通讯跟涨。 ...

Summary of Conference Call Records Company Overview - **Company Name**: Chuangyuan Xinke (创远信科) - **Established**: 2005 - **Focus**: Development of wireless communication and RF microwave testing instruments and solutions - **2024 Revenue**: 230 million CNY - **Patents**: 526 domestic and international patents - **Employees**: Approximately 230 - **R&D Centers**: Four located in Shanghai, Nanjing, Chengdu, and Zhuhai - **Stock Code**: 831,961 [2][3] Industry Focus - **Core Industry**: RF communication instruments - **Key Areas of Application**: - 5G/6G wireless communication - Vehicle networking (V2X) - Low Earth orbit (LEO) satellite and low-altitude communication [1][3] Strategic Insights - **Development Strategy**: Adopts a "1+3" strategy focusing on high-end wireless communication testing instruments applied in three areas: 5G/6G, vehicle networking, and low Earth orbit satellite communication [1][3][4]. - **Technological Advancements**: Plans to enhance vector network analyzers to 110GHz and eventually to 500GHz and terahertz bands, participating in 6G standard formulation as an IMT-2030 member [4][16]. - **Awards**: Received the National Science and Technology Progress Award (second prize) for microwave and millimeter-wave testing technology in 2023 [11]. Market Trends - **Vehicle Networking**: Increasing demand for high bandwidth and interference resistance in vehicle internal networks, with protocols like C-V2X and EUHT playing significant roles [1][6]. - **Low Earth Orbit Satellite Internet**: Projects like Starlink and China's Xingwang aim to provide ground broadband mobile internet access, integrating with future 6G technology [1][7]. - **Testing Instrument Importance**: Essential across various industries, supporting advancements in 5G/6G, vehicle networking, and low Earth orbit satellite internet [5]. Competitive Landscape - **Positioning**: Chuangyuan Xinke holds a significant position in the RF instrument industry but still lags behind global leaders like Keysight and Rohde & Schwarz [18]. - **Market Opportunities**: The trade war has created opportunities for domestic companies to replace imports, potentially increasing market share [18]. Research and Development - **Investment**: Over 100 million CNY annually in R&D, totaling 500 million CNY over the past three years [25]. - **Intellectual Property**: Holds 526 patents, with 68% being invention patents, including international patents [25]. Future Outlook - **6G Development**: 6G standards expected to be frozen by 2027 and commercialized by 2030, with Chuangyuan actively involved in R&D [29]. - **Low Altitude Economy**: Anticipated growth in demand for RF instruments as low-altitude operations expand, particularly with the integration of drones and autonomous vehicles [38]. Key Products and Solutions - **Core Products**: Includes signal sources, signal analyzers, channel simulators, and vector network analyzers, with a focus on comprehensive testing solutions for vehicle networking and satellite communication [14][15]. - **OTA Testing Solutions**: Developed for vehicle networking and intelligent driving, providing reliable data link support [15][17]. Conclusion Chuangyuan Xinke is strategically positioned in the RF communication instrument industry, focusing on high-end testing solutions for emerging technologies like 5G/6G and low Earth orbit satellites. The company is committed to innovation and has a robust R&D framework, aiming to capitalize on market opportunities while navigating competitive challenges.

Core Insights - The company won the 2023 National Science and Technology Progress Award (Second Class), marking a significant milestone after previously winning the Special Class Award in 2016 [2] - In 2024, the company reported a revenue of 233 million yuan and a net profit attributable to shareholders of 12.46 million yuan [2] - The company continues to implement its optimized "1+3" development strategy, focusing on wireless communication testing, automotive electronics, and satellite internet testing [2] Financial Performance - The company achieved a revenue of 233 million yuan in 2024 [2] - The net profit attributable to shareholders was 12.46 million yuan [2] - Research and development expenditure for the year was 104 million yuan, accounting for 44.63% of total revenue [3] Product Development and Innovation - The company launched several new products, including mmWave 5G integrated testing systems and low Earth orbit satellite internet multi-terminal testing instruments [3] - Two major national R&D projects were completed, leading to breakthroughs in key technologies and the development of advanced testing instruments [3] - The company has applied for 512 patents, including 352 invention patents, and has successfully obtained 300 authorized patents [5] Infrastructure and Talent Development - The first phase of the G60 Science and Technology Innovation Corridor headquarters was completed, aiming to create a comprehensive future technology headquarters [4] - The company announced a 2025 employee stock ownership plan with a maximum of 15.26 million shares [4] - The company is focused on talent development and building a high-level team [4]

证券代码：831961 证券简称：创远信科 公告编号：2025-009 创远信科（上海）技术股份有限公司 2024 年独立董事述职报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 饶钢先生作为创远信科（上海）技术股份有限公司（以下简称"创 远信科"或"公司"）第七届董事会独立董事和审计委员会主任，在 2024年任职期间严格按照《中华人民共和国公司法》（"《公司法》"）、 《北京证券交易所上市公司持续监管办法（试行）》、《北京证券交易 所股票上市规则（试行）》（"《上市规则》"）、《北京证券交易所上 市公司持续监管指引第 1 号——独立董事》（"《监管指引》"）、中 国证券监督管理委员会（"中国证监会"）颁布的《上市公司治理准 则（2018 修订）》等相关规定以及《创远信科（上海）技术股份有限 公司章程》（"公司章程"）、《独立董事工作细则》的规定和要求， 在 2024 年度工作中，充分发挥独立董事的作用，勤勉尽责，及时关 注公司经营发展情况，积极出席相关会议，认真审议董事会各项议案， 并对重大事项发 ...

3、公司本次员工持股计划拟参加对象符合《指导意见》及其他 法律、法规和规范性文件规定的参加条件，符合本次员工持股计划规 定的参加对象范围，其作为公司本次员工持股计划参加对象的主体资 格合法、有效。 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 创远信科（上海）技术股份有限公司（以下简称"公司"）监事 会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《关于上市公司实施员工 持股计划试点的指导意见》（以下简称"《指导意见》"）、《北京证 券交易所上市公司持续监管指引第 3 号——股权激励和员工持股计 划》（以下简称"《监管指引》"）等法律法规和《创远信科（上海） 技术股份有限公司章程》（以下简称"《公司章程》"）的规定，对公司 《2025 年员工持股计划（草案）》及其摘要等相关文件进行了核查， 经全体监事充分讨论，发表如下意见： 1、公司不存在《指导意见》、《监管指引》等法律法规、部门规 章、规范性文件和《公司章程》规定的禁止实施员工持股计划 ...

证券代码：831961 证券简称：创远信科 公告编号：2025-019 创远信科（上海）技术股份有限公司 监事会关于 2023 年股票期权激励计划 注销部分股票期权议案的核查意见 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 创远信科（上海）技术股份有限公司（以下简称"公司"）监事 会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《创远信科（上海）技术 股份有限公司章程》（以下简称"《公司章程》"）、《上市公司股权激励 管理办法》（以下简称"《管理办法》"）、《北京证券交易所上市公 司持续监管指引第 3 号——股权激励和员工持股计划》（以下简称 "《持续监管指引 3 号》"）等法律法规以及公司《2023 年股票期权 激励计划》（以下简称"《股票期权激励计划》"）的规定，对公司《关 于 2023 年股票期权激励计划注销部分股票期权的议案》进行了核查， 发表了如下意见： 本次注销部分股票期权符合《管理办法》、《持续监管指引 3 号》、《股票期 ...

证券代码：831961 证券简称：创远信科 公告编号：2025-018 创远信科（上海）技术股份有限公司 关于 2023 年股票期权激励计划 注销部分股票期权的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 创远信科（上海）技术股份有限公司（以下简称"公司"）拟注销 《2023 年股票期权激励计划》部分股票期权共 4,110,090 份，根据 《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《北京证 券交易所上市公司持续监管指引第 3 号——股权激励和员工持股计 划》（以下简称"《持续监管指引 3 号》"）等法律法规以及公司《2023 年股票期权激励计划》（以下简称"《股票期权激励计划》"）的规定， 现将有关事项说明如下： 一、本次股票期权注销审议及表决情况 2025 年 4 月 23 日公司召开第七届董事会第十六次会议审议通过 了《关于 2023 年股票期权激励计划注销部分股票期权的议案》，议案 表决结果：同意 7 票；反对 0 票；弃权 0 票。董事陈向民先生为本次 激励计划的激励对 ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0900 | 0.2400 | -62.5 | 0.1600 | | 每股净资产（元） | 5.36 | 5.28 | 1.52 | 5.01 | | 每股公积金(元) | 2.12 | 2.08 | 1.92 | 2.01 | | 每股未分配利润(元) | 2.04 | 2.01 | 1.49 | 1.84 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 2.33 | 2.7 | -13.7 | 3.18 | | 净利润(亿元) | 0.12 | 0.34 | -64.71 | 0.22 | | 净资产收益率(%) | 1.66 | 4.61 | -63.99 | 3.14 | 数据四舍五入，查看更多财务数据>> 前十大流通股东累计持有： 2908.69万股，累计占流通股比： 27.58%，较上期变化： -1025.17万股。 | 名称 ...